SOPHiA GENETICS SA Net Income 2020-2024 | SOPH

SOPHiA GENETICS SA net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
SOPHiA GENETICS SA Annual Net Income
(Millions of US $)
2023 $-79
2022 $-87
2021 $-74
2020 $-39
2019 $-34
SOPHiA GENETICS SA Quarterly Net Income
(Millions of US $)
2024-03-31 $-14
2023-12-31 $-24
2023-09-30 $-14
2023-06-30 $-21
2023-03-31 $-20
2022-12-31 $-14
2022-09-30 $-23
2022-06-30 $-25
2022-03-31 $-25
2021-12-31 $-21
2021-09-30 $-21
2021-06-30 $-18
2021-03-31 $-13
2020-12-31 $-10
2020-09-30 $-10
2020-06-30 $-8
2020-03-31 $-11
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.299B $0.062B
SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.568B 19.53
Tempus AI (TEM) United States $5.769B 0.00
Hims & Hers Health (HIMS) United States $4.337B 0.00
Inspire Medical Systems (INSP) United States $3.976B 0.00
Axonics (AXNX) United States $3.430B 0.00
IRhythm Technologies (IRTC) United States $3.348B 0.00
Olink Holding AB (publ) (OLK) Sweden $3.168B 0.00
Azenta (AZTA) United States $2.836B 159.46
Enovis (ENOV) United States $2.479B 18.37
10x Genomics (TXG) United States $2.318B 0.00
Privia Health (PRVA) United States $2.074B 115.87
Schrodinger (SDGR) United States $1.406B 0.00
Omnicell (OMCL) United States $1.243B 42.97
Phreesia (PHR) United States $1.217B 0.00
Standard BioTools (LAB) United States $0.656B 0.00
Definitive Healthcare (DH) United States $0.644B 0.00
Clover Health Investments (CLOV) United States $0.611B 0.00
Fulgent Genetics (FLGT) United States $0.587B 0.00
Talkspace (TALK) United States $0.390B 0.00
Health Catalyst (HCAT) United States $0.377B 0.00
Pulmonx (LUNG) United States $0.246B 0.00
Outset Medical (OM) United States $0.199B 0.00
Butterfly Network (BFLY) United States $0.177B 0.00
TruBridge (TBRG) United States $0.150B 8.06
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.096B 0.00
111 (YI) China $0.091B 0.00
EUDA Health Holdings (EUDA) Singapore $0.076B 0.00
SHL Telemedicine (SHLT) Israel $0.075B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
MSP Recovery (LIFW) United States $0.064B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.045B 0.00
Augmedix (AUGX) United States $0.043B 0.00
Zepp Health (ZEPP) China $0.036B 0.00
Akili (AKLI) United States $0.034B 0.00
CareCloud (CCLD) United States $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.029B 0.00
Movano (MOVE) United States $0.027B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.027B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Biotricity (BTCY) United States $0.008B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00